FDA Inspection 826561 — Agilent Technologies Denmark ApS
The FDA completed an inspection of Agilent Technologies Denmark ApS on March 14, 2013 in Glostrup. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 14, 2013
- Fiscal Year
- 2013
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Glostrup (Denmark)
Additional Details
Postmarket Audit Inspections